NDAORALCAPSULEPriority Review
Approved
May 1985
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Data completeness
3/8 — Basic
Priority Review
Drug data last refreshed 7h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
RIDAURA (auranofin) is an oral gold-based disease-modifying antirheumatic drug (DMARD) approved in 1985 for rheumatoid arthritis. It works through immunomodulatory mechanisms involving gold compound activity. The drug is administered as an oral capsule for chronic inflammatory joint disease management.
$0.994MPart D
LOE ApproachingDeclining
Approaching loss of exclusivity with minimal current spending signals a contracted team focused on maintenance rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
Auranofin for Giardia Protozoa
Started Nov 2016
93 enrolled
Amoebic DysenteryGiardiasis
Auranofin PK Following Oral Dose Administration
Started Apr 2014
15 enrolled
Amoebiasis
Career Relevance
Career opportunities on RIDAURA are concentrated in operational and logistics roles rather than commercial or medical strategy, reflecting the product's maturity. Working on this product offers stability in support functions but limited upside for advancement to strategic pharmaceutical roles.
Field Manager België
Worked on RIDAURA at Enterprise Therapeutics? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.